Optimize Cardiovascular Medical Device Development
Heart disease is the leading cause of death in the world, accounting for one-third of total global deaths in 2023. Many common heart diseases — such as arrhythmia, cardiomyopathy, coronary artery disease, and heart valve disease — can be managed, or even treated, with minimally invasive surgical intervention using different kinds of devices. Active and passive fixation devices include everything from pacemakers and ventricular assist devices (VADs) to stents and grafts. But the process to create, test, and approve these devices is lengthy and expensive.
Three-dimensional computational modeling and simulation (CM&S) solves such challenges by enabling cardiac medical device manufacturers to see what can’t be seen with the naked eye or with 2D imaging methods to optimize, expedite, and determine the best device for the patient while maintaining safety. To read the full e-book, visit ansys.com.
